Middle East

Egypt receives first batch of J&J COVID-19 vaccines

2 minute read
1/2

A vial labelled "Johnson&Johnson coronavirus disease (COVID-19) vaccine" is seen in this illustration picture taken May 2, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

Register now for FREE unlimited access to Reuters.com

CAIRO, Aug 9 (Reuters) - Egypt on Monday received its first shipment of one-shot Johnson & Johnson (JNJ.N) COVID-19 vaccines, obtaining 261,600 doses in cooperation with the African Union, the health ministry said.

The J&J vaccines will be distributed to 126 vaccination centres specifically for those who want to travel abroad, Khaled Megahed, assistant health minister for media and ministry spokesman, said in a statement.

Egypt recently began locally producing Sinovac's COVID-19 vaccines, through a deal between the Chinese company and Egypt's Holding Company for Biological Products and Vaccines (VACSERA).

Register now for FREE unlimited access to Reuters.com

The country has also received shipments of the Sputnik, Sinopharm and Oxford-AstraZeneca shots, including via COVAX, a global agreement established by the Geneva-based GAVI vaccine alliance and the World Health Organisation (WHO) for the equitable distribution of vaccines.

Egypt is reporting 54 new infections on average each day, 3% of the peak, with the highest daily average reported on June 19, according to the Reuters COVID-19 Tracker. The country has reported 284,641 infections and 16,566 coronavirus-related deaths since the pandemic began.

Egypt's prime minister said in June the government's aim was to vaccinate 40% of the population of more than 100 million against COVID-19 by the end of this year.

Register now for FREE unlimited access to Reuters.com
Reporting by Yousef Saba Editing by David Holmes

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters